Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer

© 2024. The Author(s)..

Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive tract and a leading cause of cancer-related death worldwide. Since many CRC patients are diagnosed already in the advanced stage, and traditional chemoradiotherapy is prone to drug resistance, it is important to find new therapeutic targets. In this study, the expression levels of ALDOA and p-AKT were detected in cancer tissues and paired normal tissues, and it was found that they were significantly increased in CRC tissues, and their high expression indicated poor prognosis. Moreover, a positive correlation between the expression of ALDOA and p-AKT was found in CRC tissues and paired normal tissues. In addition, the Kaplan-Meier analysis revealed that the group with both negative of ALDOA/p-AKT expression had longer five-year survival rates compared with the other group. Besides, the group with both high expression of ALDOA/p-AKT had a worse prognosis compared with the other group. Based on the expression of ALDOA and p-AKT in tumor tissues, we can effectively distinguish tumor tissues from normal tissues through cluster analysis. Furthermore, we constructed nomograms to predict 3-year and 5-year overall survival, showing that the expression of ALDOA/p-AKT plays a crucial role in predicting the prognosis of CRC patients. Therefore, ALDOA/p-AKT may act as a crucial role in CRC, which may provide new horizons for targeted therapies for CRC.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

Scientific reports - 14(2024), 1 vom: 18. März, Seite 6488

Sprache:

Englisch

Beteiligte Personen:

Xu, Menglin [VerfasserIn]
Xi, Shihang [VerfasserIn]
Li, Haoran [VerfasserIn]
Xia, Yong [VerfasserIn]
Mei, Guangliang [VerfasserIn]
Cheng, Zhengwu [VerfasserIn]

Links:

Volltext

Themen:

AKT
ALDOA
ALDOA protein, human
Colorectal cancer
Correlation
EC 2.7.11.1
EC 4.1.2.13
Fructose-Bisphosphate Aldolase
Journal Article
Prognosis
Proto-Oncogene Proteins c-akt

Anmerkungen:

Date Completed 20.03.2024

Date Revised 21.03.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-024-57209-5

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369892771